TDOC - Teladoc Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
23.15
+0.73 (+3.26%)
At close: 04:00PM EDT
23.36 +0.21 (+0.91%)
Pre-Market: 08:39AM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close22.42
Open22.35
Bid23.21 x 900
Ask23.25 x 800
Day's Range22.32 - 23.15
52 Week Range21.60 - 44.66
Volume3,944,277
Avg. Volume3,587,973
Market Cap3.789B
Beta (5Y Monthly)1.08
PE Ratio (TTM)N/A
EPS (TTM)-42.57
Earnings DateJul 25, 2023 - Jul 31, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est30.08
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TDOC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Motley Fool

    Have $2,000? 2 Remarkable Growth Stocks to Buy Right Now

    Regardless of your investing experience or risk tolerance, putting cash into stocks takes a certain tolerance for volatility and uncertainty. Investing in wonderful businesses, diversifying the ones you own, holding onto those great companies through the market's highs and lows, and avoiding traps like market timing can help you outpace the returns of the average retail investor through the years. Pfizer (NYSE: PFE) caught the attention of many investors when it became one of the leading contenders in the race to get a COVID-19 vaccine to market.

  • Motley Fool

    A Bull Market Is Coming: 2 Revolutionary Growth Stocks to Scoop Up Right Now

    No bear market period is exactly alike, and the prolonged volatility of the past year-plus understandably has some investors frustrated. Patience and fortitude are warranted to be a long-term investor, and the current market environment continues to prove that point more than ever. Teladoc Health (NYSE: TDOC) hasn't been the portfolio winner many investors had hoped for over the last year, and shares of the telehealth giant have experienced far more volatility than the average healthcare stock.

  • Motley Fool

    2 Revolutionary Stocks I'd Buy Right Now Without Hesitation

    Last year may have scared investors away from the stock market. As the market recovers, some growth stocks with strong fundamentals may thrive. Two such revolutionary companies are virtual healthcare leader Teladoc Health (NYSE: TDOC), and robotic surgery leader Intuitive Surgical (NASDAQ: ISRG).

  • Motley Fool

    Should You Buy Stocks Before a Recession?

    As we can see in the chart below, putting money into the stock market before the recession would have been a wise idea. Earlier, I briefly mentioned the idea of low valuations being a reason to invest.

  • Investor's Business Daily

    Best Cathie Wood Stocks To Watch: Coinbase, Block, Roku, Zoom Video; Tesla Surges On Ford Deal

    Cathie Wood's ARK Invest ETFs are on the rebound in 2023 after plunging in 2021 and 2022. Five ARK Invest stocks to watch include Tesla.

  • Zacks

    Why Is Teladoc (TDOC) Down 16.5% Since Last Earnings Report?

    Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Motley Fool

    Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health

    CRISPR Therapeutics (NASDAQ: CRSP) and Teladoc Health (NYSE: TDOC) both score a win when it comes to innovation in healthcare. CRISPR has developed a gene-editing approach that aims to fix faulty genes responsible for disease. Teladoc leads in telemedicine, allowing patients to visit doctors from the comfort of an armchair at home.

  • Motley Fool

    Investing $1,000 in These 2 Top Growth Stocks Would Be a Brilliant Move

    Given the market volatility over the past few years, some investors are questioning whether they should still be putting their hard-earned money into the stock market. Let's take a closer look at two excellent growth stocks to buy right now: Teladoc Health (NYSE: TDOC) and DexCom (NASDAQ: DXCM). Last year was a horror show for Teladoc.

  • Motley Fool

    2 Dirt Cheap Stocks to Buy Right Now

    These stocks are both trading at lower prices now than the lows they hit during the 2020 market crash.

  • Motley Fool

    3 Stocks You'll Be Glad You Bought at These Prices

    The good news is you really don't have to -- and you still can win in the stock market. The success of Moderna's (NASDAQ: MRNA) blockbuster coronavirus vaccine helped the stock soar earlier in the pandemic. Here's why they shouldn't: The vaccine represents just the beginning of Moderna's growth story.

  • Motley Fool

    3 Things About Teladoc That Smart Investors Know

    Teladoc Health (NYSE: TDOC) stock has been on a crazy ride the past few years, from a high of $308 in February of 2021 to a low of $21.60 this past February. The healthcare company has solid name recognition as an early mover in telehealth. Here are three things that smart investors know about Teladoc.

  • Motley Fool

    2 Beaten-Down Growth Stocks to Buy for the Long Haul

    Billionaire investor Warren Buffett says, "The stock market is a device for transferring money from the impatient to the patient." There are many impatient investors right now dumping shares of companies that have been struggling over the past year or so. Two such examples are PayPal Holdings (NASDAQ: PYPL) and Teladoc Health (NYSE: TDOC).

  • Motley Fool

    Cathie Wood Is Loading Up on These 3 Stocks Down 70% or More. Should You?

    Cathie Wood looks for stocks that are leading innovators. But the stocks that fit that mold aren't always leaders when it comes to delivering huge returns over the short term.  On the contrary, quite a few of the stocks in Wood's Ark Invest portfolios have been big losers.

  • Zacks

    Should You Hold on to Teladoc Health (TDOC) Stock for Now?

    Teladoc Health's (TDOC) cash-generating abilities are boosted by the growing number of visits and memberships.

  • Motley Fool

    If You'd Invested $10,000 in Teladoc Health in 2015, This Is How Much You Would Have Today

    A lot has changed for Teladoc Health (NYSE: TDOC) since the company's IPO in 2015. The stock is still reeling from management's dramatic misstep in overpaying for Livongo in 2020. Teladoc spent years as a telehealth company, where patients could meet with healthcare professionals digitally.

  • Motley Fool

    1 Impressive Stat That Shows How Much Teladoc Health Has Grown Since the Pandemic

    Virtual visits give doctors and patients more flexibility and can make it easier to stay on top of chronic conditions like diabetes and hypertension. Teladoc Health's (NYSE: TDOC) share price has nosedived in the past few years, but the business itself has evolved and become much bigger than it was before the pandemic began. The company's success can be illustrated with just one impressive stat: its sharp increase in virtual visits.

  • Motley Fool

    This Could Be the Biggest Mistake Investors Make This Year

    The bear market seems like it's never ending, but investors shouldn't be discouraged. Bear markets are inevitable, as are recessions, but so too are the recoveries that follow. Buying and holding is what has made investors like Warren Buffett hugely successful over the years.

  • InvestorPlace

    The 3 Best MedTech Stocks to Watch in May 2023

    Finding the best MedTech stocks to watch in May can be a challenge. After all, the category is huge. MedTech encompasses many types of sectors like medical devices, cloud applications, artificial intelligence (AI), and diagnostic systems. Yet there are many positive catalysts for the industry. Just look at AI. A recent study from JAMA Internal Medicine highlights how innovation is improving healthcare. It compared human doctor advice to that of ChatGPT. The results? Well, based on a peer review

  • Motley Fool

    3 Best Stocks to Buy in May and Hold Forever

    In need of healthcare exposure in your portfolio? Consider holding these three promising companies forever.

  • Motley Fool

    More Likely to 5X First: Teladoc vs. InMode

    Teladoc Health (NYSE: TDOC) and InMode (NASDAQ: INMD) both operate in high-growth industries. Teladoc is a leader in telemedicine. InMode specializes in selling devices in the minimally invasive and non-invasive aesthetics market.

  • Simply Wall St.

    In the wake of Teladoc Health, Inc.'s (NYSE:TDOC) latest US$157m market cap drop, institutional owners may be forced to take severe actions

    Key Insights Significantly high institutional ownership implies Teladoc Health's stock price is sensitive to their...

  • Motley Fool

    Is Teladoc Health Stock About to Take Off Again?

    On April 26, Teladoc Health reported its earnings numbers for the period ended March 31. A big positive was that the business's growth rate remained resilient. While that's not as strong as the figures achieved during the early stages of the pandemic, when the stock was a red-hot buy, the growth rate hasn't fallen into the negative.

  • InvestorPlace

    Which Healthcare Stock Is a Compelling Pick for the Long Haul?

    Investors remain puzzled due to persistent macro challenges, continued interest rate hikes, and the regional banking crisis. Given the ongoing uncertainties, sectors that are resilient during economic downturns could offer attractive investment opportunities. While not entirely immune to recessionary conditions, healthcare companies have the ability to navigate a tough macro backdrop due to the essential nature of their products and services. An increased focus on health since the Covid-19 pande

  • Motley Fool

    Is The Worst Over for Teladoc?

    Teladoc Health (NYSE: TDOC) is finally getting some love from investors. The company's latest quarterly report was also well-received by the market, which helped jolt its stock further. Before jumping on the bandwagon, it's essential to look deeper into Teladoc's operations and determine whether the company has solid long-term prospects.

  • Motley Fool

    Want to Get Richer? 2 Best Stocks to Buy Now and Hold Forever

    Virtual healthcare company Teladoc Health (NYSE: TDOC) experienced some exceptional gains during the worst of the pandemic. When the pandemic subsided and hospitals reopened, investors expected telehealth services would no longer be in demand and dumped the company's stock, causing it to plummet. Teladoc, on the other hand, is demonstrating that it can not only survive but thrive in the post-pandemic market.